Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)	Arrhythmias, Cardiac, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, metabolic disease	Recruiting	Phase 3	2026-04-01		NCT05174052

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Oklahoma	146

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Oklahoma Health Sciences Center	Oklahoma City	United States	491

Clinical trials